Share Name Share Symbol Market Type Share ISIN Share Description
Quantum Phar. LSE:QP. London Ordinary Share GB00BRTL8Q42 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 40.50p 39.00p 42.00p - - - 8,913.00 16:21:12
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 70.0 6.2 4.5 9.0 68.49

Quantum Phar. Share Discussion Threads

Showing 1326 to 1347 of 1350 messages
Chat Pages: 54  53  52  51  50  49  48  47  46  45  44  43  Older
DateSubjectAuthorDiscuss
21/3/2017
13:05
Something going on. Rise in share price but can't find any news
werewolfie
20/3/2017
16:45
Can't argue with Aspringo. I bought at 1.28 now we are at 40p. But Rose has made some good points. Looks like they are learning from their mistakes
werewolfie
17/3/2017
14:09
Aspringo... I cannot disagree. My thoughts are this.. Old QP Board now gone..New CEO and new CFO and New Board in Place with new Strategy. Fund raising of £15 mill successful... Nu Pharm Closed with losses hopefully capped. The future is about focus on where both profitability and growth has been identified.. and that is where the company is going..Instead of a sprawling empire QP will be or should become a highly profitable niche player in its target markets.. There is nowa really strong and experienced board overseeing QP Management.. There is a strong Institutional presence on the shareholder register.. and the company together with its Biodose services can make a real play to become (with partners) a major supplier to the NHS and Health Services across the UK.. It may also prove attractive to a bigger player wanting to enter these markets.. Big buyers are out there for the shares .. We may know who very soon.
rosejs2
17/3/2017
13:28
Probably the most disappointing share ive owned
aspringo
22/2/2017
18:34
Investor Roadshow INMO I think the investor roadshow is a positive sign..Generally companies try to gauge from investors as to what drives them to invest in a stock.. They also try to see how in a positive way they can release RNS announcements without misleading investors together with how they time them. A roadshow like this is not the same as an IPO roadshow so hopefully we will see some positive buying on the back of it.
up protherics
21/2/2017
17:12
I'm always wary of roadshows. Why bother if you don't want to raise money. It's managements job to run the business not pander to existing investors or the share price.
r ball
21/2/2017
10:55
I see that QP. are undertaking an investment roadshow from tomorrow (22/2) via N+1 Singer. Hopefully this means they have a good story to tell following the year end trading update and will start appearing on institutional buy lists again.
rivaldo
16/2/2017
15:35
Vitamin supliments have been getting good press coverage recently. So hopefully this will add to sales for Quantum
up protherics
10/2/2017
07:49
Harwood are ok activist. Welcome oversight.
r ball
09/2/2017
19:57
Most of the placing shares are held by one investor Harwood..From past experience they will want to hold the stock until they get a decent return.. Judging by the the price the options have been fixed at we should be looking at northwards of 1.40 within three years.. That's of course if everything goes well. As a separate issue does anyone know how much royalties quantum receive on MED2002..and are they involved with phase 111 trialing
up protherics
09/2/2017
17:29
Lol - the trouble this share now has is there is big supply all the way up which will take a hell of a lot of buying to shift - so I am staying well clear for a considerable time now
davr0s
09/2/2017
13:48
Sellers cleared
nw99
06/2/2017
11:42
Good recommendation write up this month in SCSW plus recent Director buying so I have bought in today.
adorling
01/2/2017
16:21
May as well wait for the obvious drift downwards back to placing price.
a2584728
01/2/2017
10:28
N+1 Singer are similarly reassured and have a 65p valuation, which "could be substantially higher on a 2-3 year view": Extracts: "Reassuring FY trading update An in line trading update should reassure that Quantum’s new management team is delivering on its promises. EBITDA is expected to be in line with expectations and, pleasingly, Net Debt is expected to be ~£1m lower, reflecting the focus on cash management. All the UL2L products in the pipeline are now in active development and work has begun on broadening the group’s commercial network to help monetise the generic products already developed. We make no change to our forecasts and look forward to further positive newsflow at the prelims in early May." "N+1 Singer view The shares have recovered well from the placing price of 34p in October but still, in our opinion, do not capture the full value of the opportunity. Our DCF analysis suggests an intrinsic value of 65p per share on current estimates. With good execution and full delivery of the UL2L pipeline, this figure could be substantially higher on a 2-3 year view."
rivaldo
01/2/2017
07:45
Burnt through £5m cash since Interims
r ball
01/2/2017
07:35
Pretty reassuring/encouraging trading update - in line with expectations, which per N+1 Singer are 3.9p EPS for the year just ending: Http://www.investegate.co.uk/quantum-pharma-plc--qp--/rns/full-year-trading-update/201702010700086675V/ And sounding optimistic going forward: "As a result of these actions to tighten strategic focus, the current performance of the Group is supportive of market expectations for the year ending 31 January 2018"
rivaldo
26/1/2017
10:13
went out with a wimper last night, your leeds (if i recall correctly) boys doing well too wc
woodcutter
25/1/2017
19:57
Woody, Yes, long time. Good to see the Scouse Mouse roar under Klopp. QP. could be one of those value traps which go sideways whilst they prove up they can meet the figures and then rerate if they can get ahead. No hard sign of that yet with the new CEO only in place for six months, normally takes a while to shake up the operating business. CR has a formula on the timing of when a new CEO comes in, I've forgotten exactly what it was but I think it was to look after a year. Good fortune
simon gordon
25/1/2017
19:27
Picked up 5000 today for a long term hold small dip to start... looks well from hear also a substantial but after mine :)
g2theary
25/1/2017
13:58
Hi simon HNY to you too long time no speak as they say. Sorry i should've posted but i sold at 48p when the chart indicators weakened and it didn't move as expected. That's too small losses now so I'm inclined to wait for some serious chart move now. i reread the wording from interims and concluded that this was more significant than the director purchases, coupled with the chart indicators i decided to sell if it drops back to gap support around 40p i'll take another look but for now i've passed. I'm using TA and charting more than ever these days backed up by the FA of course but's that's becoming more and more secondary in my decision making. I'm not hanging around in this market as i feel it's very top priced so anything that doesn't do as i expect i'm closing quickly. I had a busy year last year with little time on investing so I'm still very much in cash just drip feeding in to the market slowly. still think there's a major correction coming, who knows when though, probably later this year when trumpanomics hits the floor. woody
woodcutter
12/1/2017
17:25
Hi Woody, Happy New Year. How much upside are you sensing on this one, according to Sharescope they are on 15x to January 2018 and 12x to January 2019. Are you expecting upgrades to those N+1 forecasts?
simon gordon
Chat Pages: 54  53  52  51  50  49  48  47  46  45  44  43  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20170330 00:55:50